ASX:COH Cochlear (COH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Cochlear Stock (ASX:COH) 30 days 90 days 365 days Advanced Chart Get Cochlear alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume201,277 shsAverage VolumeN/AMarket CapitalizationA$19.88 billionP/E Ratio55.90Dividend Yield1.35%Price TargetN/AConsensus RatingN/A Company Overview Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia. Read More Receive COH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address COH Stock News HeadlinesCochlear Limited Reports FY25 Growth and Launches Innovative Implant SystemAugust 15 at 3:27 AM | msn.comCochlear Limited Announces 2025 AGM DetailsAugust 14 at 10:27 PM | theglobeandmail.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. | Brownstone Research (Ad)Cochlear FY25 earnings: revenue and profit climb, dividend up 5%August 14 at 10:27 PM | msn.comCochlear Limited Releases 2025 Tax Contribution ReportAugust 14 at 10:27 PM | msn.comAre Cochlear Limited (ASX:COH) Investors Paying Above The Intrinsic Value?August 8, 2025 | finance.yahoo.comAssistive tech targets market growth while improving livesAugust 6, 2025 | msn.comHealth Check: Aussie biotechs are navigating a US regulatory minefieldJuly 22, 2025 | msn.comSee More Headlines COH Stock Analysis - Frequently Asked Questions How were Cochlear's earnings last quarter? Cochlear Limited (ASX:COH) posted its quarterly earnings data on Tuesday, February, 19th. The company reported $2.15 earnings per share for the quarter, missing the consensus estimate of $2.19 by $0.04. Cochlear had a net margin of 15.80% and a trailing twelve-month return on equity of 19.70%. What other stocks do shareholders of Cochlear own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cochlear investors own include CSL (CSL), ResMed (RMD), NIB (NHF), Accent Group (AX1), Corporate Travel Management (CTD), Mineral Resources (MIN) and Technology One (TNE). Company Calendar Last Earnings2/19/2019Today8/16/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:COH CIKN/A Webwww.cochlear.com Phone+61-2-94286555FaxN/AEmployees4,996Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$5.43 Trailing P/E Ratio55.90 Forward P/E RatioN/A P/E Growth3.87Net IncomeA$356.80 million Net Margins15.80% Pretax MarginN/A Return on Equity19.70% Return on Assets11.99% Debt Debt-to-Equity Ratio13.24 Current Ratio2.30 Quick Ratio1.93 Sales & Book Value Annual SalesA$2.24 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow123.45 Book ValueA$28.10 per share Price / BookN/AMiscellaneous Outstanding Shares65,500,000Free FloatN/AMarket CapA$19.88 billion OptionableNot Optionable Beta0.47 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (ASX:COH) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cochlear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.